PCRX
PCRX
NASDAQ · Pharmaceuticals

Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$25.02
-0.56 (-2.19%)
As of Aug 9, 10:14 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 8 67%
Hold 3 25%
Sell 1 8%
Price Target
Analyst Price Target -9.2% upside
Low Target $15.64
Average Target $22.71
High Target $35.67
Current Price $25.02
Current
$25.02
Target
$22.71
$15.64 $22.71 avg $35.67
Scenario Analysis
Bear Case
$15.64
-37.5%
Low target
Base Case
$22.71
-9.2%
Avg target
Bull Case
$35.67
+42.6%
High target
Risk/Reward
1.1x
Balanced
Price in Context
52-Week High
$27.66
-9.5% from high
52-Week Low
$18.80
+33.1% from low
Target vs 52W High
$22.71
-17.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%